Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma
ModeX Therapeutics, An OPKO Health Company
ModeX Therapeutics, An OPKO Health Company
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Turning Point Therapeutics, Inc.
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Essen Biotech
Intensity Therapeutics, Inc.
Hutchmed
University Hospital, Basel, Switzerland
Bayer
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
Novartis
National Institutes of Health Clinical Center (CC)
Shenzhen BinDeBio Ltd.
Masonic Cancer Center, University of Minnesota
RedHill Biopharma Limited
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Kentucky
Northwestern University
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
NYU Langone Health
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center